Introduction to contraindications for capmatinib

Capmatinib (Capmatinib), as an innovative drug for the treatment of non-small cell lung cancer, has significant efficacy, but there are also some contraindications that require special attention. The following will introduce the contraindications of capmatinib in detail to help patients and doctors better understand and apply this drug.

First, capmatinib is not suitable for patients who are allergic to the ingredients in the drug. Anaphylaxis can include severe symptoms such as difficulty breathing, rash, and throat swelling, and can even be life-threatening. Therefore, before using capmatinib, patients must undergo allergy testing to ensure they do not have an allergic reaction to the drug's ingredients.

Secondly, capmatinib is also contraindicated in patients with hepatic impairment. Capmatinib needs to be metabolized by the liver in the body. If liver function is damaged, it may cause the drug to accumulate in the body and increase the risk of adverse reactions. Therefore, patients with hepatic insufficiency should undergo liver function tests before using capmatinib and decide whether to use it based on the doctor's advice.

In addition, capmatinib is contraindicated in pregnant and breastfeeding women. Capmatinib may cause damage to the fetus and even cause miscarriage or malformations. Therefore, pregnant women should avoid using capmatinib during pregnancy. At the same time, because capmatinib may be secreted through breast milk, breastfeeding women should also avoid using this drug to avoid adverse effects on the baby.

It should be noted that although capmatinib has made significant progress in the treatment of non-small cell lung cancer, it is not suitable for all patients with non-small cell lung cancer. Only those patients with specific genetic markers, such as MET exon 14 skipping mutations, benefit from capmatinib treatment. Therefore, before using capmatinib, patients need to undergo genetic testing to determine whether they are suitable for the drug.

In summary, capmatinib, as an innovative drug, has significant efficacy, but there are also contraindications for its use. Patients should consult their doctor before use to understand whether they are suitable for using this drug, and use the drug strictly in accordance with the doctor's instructions to ensure safe and effective treatment of non-small cell lung cancer.